Navigation Links
Preterm Infants with Respiratory Distress Syndrome: Incidence Rates,of Death when Treated with Surfactant Replacement Therapies

ong RDS babies treated with poractant alfa at an initial dose of 200 mg/kg than with beractant. Results from this large database analysis are consistent with the findings of our trial and other similar trials comparing poractant alfa and beractant. Furthermore, these analyses also demonstrated statistically significant survival benefits with poractant alfa treatment when compared with the other two natural surfactants available for clinical use in the United States. These results suggest that neonatologists should carefully weigh their choice of surfactant therapy in their clinical practice."

The study presented today was supported by a research grant from Chiesi Farmaceutici of Parma, Italy, manufacturer of Curosurf(R) Intratracheal Suspension, and Dey, L.P., US marketer of Curosurf(R).

"We are pleased to have supported this study and are impressed with its results," said J. Melville Engle, President and Chief Executive Officer of Dey, L.P. "To the extent that these data will affect clinical practice, these outcomes bode well for the health of premature infants and the peace of mind of their families."

Paolo Chiesi, Vice President, R&D Director of Chiesi Farmaceutici, concurred: "Curosurf(R) is already the most widely used surfactant in the world, and we look forward to its being used to treat more babies suffering from RDS in the United States. We are delighted that this large data analysis so strongly validates the clinical value of Curosurf(R)."

About Curosurf(R)

Curosurf(R) Intratracheal Suspension is indicated for the treatment (rescue) of RDS in premature infants. Curosurf(R) reduces mortality and pneumothoraces associated with RDS.

Curosurf(R) Intratracheal Suspension compensates for the deficiency of surfactant in preterm infants with RDS and restores surface activity to the lungs of these infants. Because Curosurf(R) works rapidly, infants should receive frequent clinical and laboratory assessments so that oxyg
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
2. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
3. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
4. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
5. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
6. Alnylam Reports Results of Human Experimental Infection Model with Respiratory Syncytial Virus
7. Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
8. DVT Awareness Survey Findings: Heart and Respiratory Patients
9. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
10. New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer Protein, Causing Cancer Cell Death
11. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
Post Your Comments:
(Date:3/26/2015)... , March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... with a focus on Omega-3 therapies for cardiovascular disease ... it issued 763,752 common shares of the Corporation (the ... for the period of December 5 th , 2014 ... Convertible Notes that is due on or before April ...
(Date:3/26/2015)... March 26, 2015 According to ... Procedure Volume, Technology (RF, Microwave, Cryoablation, Others), Department (Interventional ... Cancer, Bone Metastasis) - Global Forecasts to 2019", published ... reach around $462.0 Million growing at a CAGR of ... tables and 57 figures spread through 195 pages and ...
(Date:3/26/2015)... March 26, 2015 Zimmer Holdings, Inc. (NYSE ... ® Advanced Bearing Technology with Vitamin E by ... published earlier this month reported that, at 96 million ... Advanced Bearing Technology featuring Vitamin E grafted highly crosslinked ... wear rate reduction of 95 percent, with no cracking, ...
Breaking Medicine Technology:Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
... and the veterans returning from war, MCU, Inc launches ... educate those wanting to help our chronically ill and ... of Medical Cannabis Therapy. Using modern ... instructors gain much needed employment utilizing the internet to ...
... WARRENDALE, Pa., Sept. 17 At MEDRAD, Inc., ... year marks MEDRAD,s 11th annual Day of Caring, ... opportunity to spend a workday volunteering in their ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO) Over 1000 MEDRAD employees ...
Cached Medicine Technology:Medical Cannabis University™ Launches, Puts Thousands Back to Work to Help Veterans and the Chronically Ill 2MEDRAD Employees Demonstrate Longstanding Commitment to Community 2MEDRAD Employees Demonstrate Longstanding Commitment to Community 3
(Date:3/27/2015)... Trail mix is the perfect, healthy snack for families on ... the game! It’s portable, lightweight and provides a wide range ... new line of specialty trail mixes that satisfy your hunger ... with nutritious, 100% all natural ingredients. , These tasty combinations ... and fiber to your diet and boost energy. The mixes ...
(Date:3/27/2015)... Jersey (PRWEB) March 27, 2015 Airy ... has released the official music video for her debut ... , Combining live-action and abstract styling effects, the ... be viewed on YouTube, Vimeo, and assorted outlets. It ... the development of an expanding full-scale marketing strategy. The ...
(Date:3/27/2015)... Hawkins, Pastor and Overseer at The House of Yahweh in ... is through the Laws of Peace written in the Holy ... article titled, “Yahweh’s Way-The Great Difference” focuses on the past ... the original biblical instructions has caused mass chaos worldwide. ... in the world is based on man-made laws that will ...
(Date:3/26/2015)... March 26, 2015 Elfster.com, the top-rated ... of its bucket list generator capabilities to its leading ... refers to a list that one creates of things ... 2007 movie of the same name. Nowadays many ... to memorialize their summer achievements. , "We are greatly ...
(Date:3/26/2015)... 2015 UC Davis will establish a ... origins of schizophrenia: A Silvio O. Conte Center for ... such centers in the United States. , The center ... the National Institutes of Mental Health, which will allow ... that an origin of schizophrenia may be dysregulation of ...
Breaking Medicine News(10 mins):Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2Health News:Plans for Bucket List Generator - Just In Time for Summer - Announced by Elfster 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4
... The March for Babies 2008 Official Shoes are Now On ... of,Dimes has teamed up with Famous Footwear(TM) and Dr. Scholl,s(R) ... For the third consecutive year, Famous Footwear and Dr. Scholl,s ... walking shoe styles.,Dr. Scholl,s specially designed one men,s and two ...
... Dialysis Corporation,of America (Nasdaq: DCAI ) announced today ... year financial results on March 13, 2008, after the,close ... conference calls,in conjunction with its quarterly earnings releases, beginning ... following morning, March 14,2008 at 10:00 AM EDT., ...
... JERSEY, FEBRUARY 29 -- Otsuka Pharmaceutical Co., Ltd. and ... U.S. Food and Drug Administration (FDA) approved the supplemental ... treatment of manic and mixed episodes associated with Bipolar ... patients (10 to 17 years old). ABILIFY has ...
... study in the Mojave Desert, Calif., has found that soils ... a type of salt, close to the surface. Vulnerable to ... disrupted, this vast source of nitrate could contaminate surface and ... appear in the March issue of Geology . , ...
... of Hematology announce a new partnership to publish the ... available (back to 1997) on Springers online information platform ... and was previously published by Carden Jennings. , Since ... official journal of the Japanese Society of Hematology (JSH), ...
... ATLANTA, Feb. 29 Children,s Healthcare of Atlanta, ... today a,landmark investment in the future of pediatric ... $430 million of the Children,s,endowment toward pediatric research., ... will be,invested in pediatric research," said James E. ...
Cached Medicine News:Health News:Famous Footwear, Dr. Scholl's Step Up to Support March for Babies 2008 2Health News:Dialysis Corporation of America Announces Fiscal Year 2007 Earnings Release Date 2Health News:ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 2Health News:ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 3Health News:ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 4Health News:Large source of nitrate, a potential water contaminant, found in near-surface desert soils 2Health News:Large source of nitrate, a potential water contaminant, found in near-surface desert soils 3Health News:Springer to publish International Journal of Hematology 2Health News:Children's Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision 2Health News:Children's Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision 3
... The UVS800DDA Universal Vacuum Source is a ... Cold Trap and 4-headed, Oil-free Vacuum Pump. It ... chemistry use and abuse., Combines a ... single housing eliminating extra tubing connections. ...
... designed for a wide variety of laboratory applications. ... eliminates oil mist vapors because it doesn't consume ... less fuss., Quiet, efficient operation ... ETFE and PFA heads , Recommended ...
... several different two-stage, oil-sealed, rotary vane vacuum ... applications. Each pump comes complete with a ... and Oil Mist Filter (EMF-10). The GBORK ... ballast to keep the oil clean without ...
Produces vacuum pressures required for 96 well kits...
Medicine Products: